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Modified oligonucleotides continue to play an important role as antisense compounds that
inhibit the expression of genes associated with metabolic disorders, cancer, and infectious
diseases. Because the majority of modifications render these molecules refractory to standard
enzymatic sequencing techniques, alternative sequencing methods which are fast and reliable
are needed. In this work we explore how sugar and backbone modifications affect fragmen-
tation patterns observed from oligonucleotides which are fragmented by infrared multiple
photon dissociation in the external reservoir of an electrospray ionization Fourier transform
ion cyclotron mass spectrometer. The modifications influence which fragment types (i.e., an-B
versus cn) dominate and the ease with which the oligonucleotides are fragmented. General
observations for confirming the sequence of oligonucleotides are described. (J Am Soc Mass
Spectrom 2003, 14, 825–833) © 2003 American Society for Mass Spectrometry
Antisense compounds are modified oligonucleo-tides that bind messenger RNA and inhibit theexpression of genes associated with metabolic
disorders, cancer, and infectious diseases. Modified
oligonucleotides are necessary to increase the binding
of the oligonucleotides to the messenger RNA as well as
to minimize the in vivo enzymatic degradation of the
oligonucleotides [1]. Typically, modifications are made
to the phosphate backbone and to the 2 position of the
sugar. Fast and reliable methods are needed for se-
quencing these oligonucleotides since standard enzy-
matic techniques are not compatible with the majority
of these modifications.
Mass spectrometry has developed into a powerful
tool for studying macromolecules of biological impor-
tance, including nucleic acids. Soft ionization tech-
niques such as electrospray ionization [2–4] and matrix-
assisted laser desorption/ionization [5, 6] allow the
introduction of large intact biomolecules into the gas
phase for mass spectrometric analysis. In addition to
accurate molecular weight determination, mass spectro-
metry in combination with different fragmentation
schemes provides information about sequence and/or
structure of the biomolecules. Seminal work by McLaf-
ferty and coworkers demonstrated the ability to obtain
partial sequence information for DNA oligonucleotides
up to 108 nucleotides in length using tandem mass
spectrometry techniques on a FTICR spectrometer [7].
By combining various fragmentation schemes, it was
shown that complete sequence coverage could be ob-
tained for a 50-mer DNA [7–9]. Other researchers dem-
onstrated that sequence information and identification
of modified bases could be obtained by combining
fragmentation schemes with ion trap mass spectro-
metry [10] and triple quadrupole mass spectrometry
[11–13].
Based on the small amounts of sample required and
the unambiguous signatures generated, mass spectro-
metry is emerging as the preferred platform on which to
interrogate and sequence modified oligonucleotides. In
order to faithfully sequence oligonucleotides containing
desperate chemical modifications, an understanding of
how the modifications influence the fragmentation pat-
tern is essential. One of the motivating factors behind
this work was the desire to rapidly confirm the pur-
ported sequence of a modified oligonucleotide regard-
less of the chemical modifications employed in the
synthesis. While a mass measurement of an intact
oligonucleotide that is consistent with the expected
sequence is generally adequate, there are many cases in
which sequence verification is a prerequisite to animal
toxicity studies or clinical trials involving human sub-
jects. It is possible that an oligonucleotide could be
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erroneously synthesized with the correct base compo-
sition but incorrect sequence. Although the focus of this
work is sequence confirmation, the observations and
conclusions derived herein should be equally applica-
ble to the de novo sequence determination of modified
oligonucleotides. In this work, infrared multiple photon
dissociation in the external reservoir of an electrospray
ionization Fourier transform ion cyclotron resonance
mass spectrometer (InHex IRMPD ESI-FTICR MS) is
used to investigate the influence of chemical modifica-
tions on the fragmentation patterns of oligonucleotides.
Experimental
Chemicals
Table 1 shows the sequences and modifications of
oligonucleotides used in this study. All oligonucleo-
tides were synthesized using standard phosphorami-
date chemistry. All oligonucleotides were purified by
ethanol precipitation as ammonium salts. 15 M solu-
tions of each oligonucleotide were prepared in 50:50
isopropanol/water solution containing 0.1% tripro-
pylamine.
Instrumentation
All experiments were performed on a Bruker Daltonics
(Billerica, MA) Apex 70e Fourier transform ion cyclo-
tron resonance mass spectrometer. The spectrometer is
equipped with an Analytica (Branford, CT) electrospray
source utilizing a grounded ESI emitter, a glass desol-
vation capillary with countercurrent drying gas, and an
external ion reservoir. The external ion reservoir con-
sists of a biased skimmer cone, an rf-only hexapole ion
guide and a gate electrode at the low-pressure end of
the hexapole ion guide. Ions are accumulated in the
external ion reservoir (concurrent with IR irradiation
for the IRMPD experiments) for 0.5–1 s and pulsed into
the Infinity trapped ion cell for analysis by FTICR [14].
The oligonucleotides were analyzed in the negative
mode with the potential applied to the capillary exit
maintained at50 V to avoid nozzle-skimmer fragmen-
tation. The skimmer cone voltage is held at 0 V and the
gate electrode toggles between 20 V during accumu-
lation and 20 V during ion ejection. The ions are excited
and detect from 440 to 5000 m/z values. Thus, fragment
ions with m/z values 440 such as a2-B and w1 will not
be observed under these experimental conditions. All
aspect of the experiment including data acquisition,
processing, and plotting were performed using Bruker
XMASS version 5.0 software running on a dual proces-
sor Pentium PC.
IRMPD
A 25 W continuous wave CO2 laser (Synrad Inc.,
Mukilteo, WA) operating at 10.6 m was used for all
IRMPD experiments. Using standard IR-compatible
mirrors and kinematic mirror mounts, the unfocused 3
mm laser beam was aligned to traverse through the
length of the instrument from the infinity cell to the
hexapole ion guide and finally impinge upon the skim-
mer cone [14]. The laser was operated at an output
range of 10–28 W as measured at the entrance to the
mass spectrometer; no attempt was made to determine
the actual laser power in the hexapole ion guide. The
ions were irradiated in the hexapole ion guide during
the ion accumulation event.
Data Analysis
Using a computer program written in house, the mo-
noisotopic neutral mass and the monoisotopic peak of
the 1- to 5- change states of all possible an, an-B, bn, cn,
wn, xn, and yn fragment ions were generated from the
expected oligonucleotide sequence. The InHex IRMPD
mass spectrum of the oligonucleotide is deconvoluted
using ICR-2LS [15] which generates a list containing the
identified peak, charge state, absolute abundance (arbi-
trary units) and calculated monoisotopic neutral mass.
The list of predicted fragment ions is compared to the
monoisotopic neutral masses calculated from the exper-
imentally observed peaks and as shown for Oligo 7 in
Figure 1B, the deconvoluted spectrum is labeled with
the appropriate fragment. Since some fragment ions
will overlap in the raw mass spectrum as shown in the
Table 1. Sequence, sugar, and backbone of oligonucleotides used in this study
Oligonucleotide Sequence Sugar Backbone
Oligo 1 TGA5GGATG55AG5TTGGG5T 2-deoxyribose Phosphodiester
Oligo 2 TGA5GGATG55AG5TTGGG5T 2-deoxyribose Phosphorothioate
Oligo 3 GCGTTTGCTCTTCTTCTTGCG 2-deoxyribose Phosphorothioate
Oligo 4 GTTCTCGCTGGTGAGTTTCA 2-deoxyribose Phosphorothioate
Oligo 5 T5TT55A5TGT5TTTT5A 2-deoxyribose Phosphorothioate
Oligo 6 GATG55AGAGAGGATG55 2-deoxyribose Phosphorothioate
Oligo 7 GCCCAAGCTGGCATCCGTCA 2-deoxyribose Phosphorothioate
Oligo 8 GCCCAAGCTGGCATCCGTCA Ribose Phosphorothioate
Oligo 9 GCCCAAGCTGGCATCCGTCT 2O-methoxyethyl ribose Phosphorothioate
Oligo 10 GATG55AGAGAGGATG55 2-deoxyribose, 2-O-methoxylethyl ribose Phosphorothioate
Note: 5  5 methyl C.
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inset of Figure 1a and may not be deconvoluted cor-
rectly, missing fragment ions necessary for sequence
confirmation are searched for in the raw spectrum using
the generated list of predicted fragments. If there are
unidentified peaks with significant absolute abundance,
it is verified that the peaks do not correspond to
alternative sequences. When all fragment ions have
been identified, the absolute abundance of each charge
state for the individual fragment ions are summed to
give a total absolute abundance of that fragment (i.e.,
the abundance of the 1- and 2- charge states of a5-A
fragment are summed together to give a total absolute
abundance for the a5-A fragment). The total fragmenta-
tion abundance of the oligonucleotide is then calculated
by summing the total absolute abundance for each
fragment and normalizing to 1. This way, the abun-
dance of the individual fragments represent a fraction
of the total fragmentation abundance and can be dis-
played in bar graphs (e.g., Figure 2a). The observed
order of preference for fragmentation on the 3 side of a
base for each fragment type was established by deter-
mining the percentage of fragmentation occurring 3 to
each base for a given fragment type, dividing the
percentage of fragmentation at each base by the number
of times that base occurs in the sequence and rank
ordering based on the normalized percentage of frag-
mentation.
Results and Discussion
Background
Throughout this paper we use the standard oligonucle-
otide fragmentation nomenclature established by
McLuckey et al. [16]. Several dissociation schemes have
been used in combination with mass spectrometry to
fragment DNA oligonucleotides of various lengths.
These methods include nozzle-skimmer dissociation
[17], collisional activated dissociation (CAD) [12, 13],
infrared multiple photon dissociation (IRMPD) [18],
blackbody infrared radiative dissociation (BIRD) [19],
and multipole storage assisted dissociation (MSAD)
[20]. Several groups have shown that modified bases
influence fragmentation patterns of oligonucleotides
and can be used to locate modified bases that occur
naturally in damaged DNA [10, 21–24]. The effect of
replacing the phosphate groups with methylphospho-
nates on the fragmentation patterns of DNA has also
been investigated, indicating that fragmentation can
occur at non-ionized linkage sites [25, 26].
Recently, we demonstrated the utility of performing
IRMPD in an external ion reservoir [14]. In this scheme,
a laser beam traverses the external ion reservoir during
the ion accumulation event and causes fragmentation of
the molecular ions. Because ions are exposed to a range
of laser irradiation times, increased sequence coverage
and fragmentation ion yields are observed. Addition-
ally, because the external ion reservoir is at a relatively
high pressure, the ions undergo a large number of
low-energy collisions that stabilize metastable frag-
ments, which would otherwise go undetected. Unlike
in-cell CAD approaches that require transiently ele-
vated analyzer cell pressure followed by an extended
pump down time before excitation and detection, InHex
IRMPD is performed without modulating the pressure
in the analyzer cell and is thus very rapid. Owing to the
inherent complexity of the resulting mass spectra, the
FTICR is an ideal platform on which to make such
measurements. For the spectra shown in this work,
average resolving power in excess of 100,000 (FWHM)
was routinely obtained concurrent with 2 ppm mass
measurement error. Such performance facilitates the
unambiguous assignment of fragments.
Figure 1. Mass spectrum of the InHex IRMPD fragmentation of
the phosphorothioate deoxyoligonucleotide 5-GCCCAAGCTG-
GCATCCGTCA-3: (a) raw mass spectrum and (b) deconvoluted
mass spectrum. Only the an-B and wn fragment ions have been
labeled. In (a), peaks corresponding to residual intact oligonucle-
otide are labeled with an asterisk and the inset shows that closely
space fragment ions can be resolved when ESI-FTICR-MS is used.
In (b), the arrow marks the calculated mass of the a9-T fragment,
which is clearly not observed.
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Comparison of Phosphodiester
and Phosphorothioate Backbones
Since one of the most commonly employed chemical
modifications in antisense compounds is the replace-
ment of an oxygen atom of the phosphodiester linkage
(PO4) with a sulfur atom to form a phosphorothioate
linkage (PSO3), a comparison between the fragmenta-
tion patterns of a 21-mer phosphodiester oligonucleo-
tide (Oligo 1) and a 21-mer phosphorothioate oligonu-
cleotide (Oligo 2) with the same sequence was made
(Table 2). In Table 2, the absolute abundances (arbitrary
units) for the each charge state of a fragment are
summed together and then the fragments are normal-
ized to 1 based on the most abundant fragment. For
both the phosphodiester and the phosphorothioate oli-
gonucleotides an-B and wn fragment ions dominate,
accounting for over 85% of the fragment ions. For both
oligonucleotides, no an-B fragment ions and decreased
wn fragment ions are observed at the 3 side of T.
Previous studies have also observed a decreased ten-
dency for fragmentation at the 3 side of a T [7, 8, 22,
26–30]. While McCloskey and coworkers did not ob-
serve the an-5MeC fragment ion under CID conditions
[12], the an-5MeC fragment ion is observed for both
oligonucleotides using the InHex IRMPD fragmentation
scheme (Table 2). For both oligonucleotides, yn frag-
ment ions account for 4-6% of the total fragment ions. In
contrast, bn and cn fragment ions each account for less
than 4% of the total fragment ions exclusively in the
phosphorothioate oligonucleotide — appreciable abun-
dances of bn and cn fragment ions are not observed in
the construct with the phosphodiester backbone. In
each case, sufficient fragmentation was observed to
confirm the sequence of the oligonucleotides. Since the
overall fragmentation patterns are similar for the two
different backbones and phosphorothioate backbones
are widely used in antisense compounds, all studies
presented below employ a full phosphorothioate back-
bone.
Figure 2. InHex IRMPD fragmentation patterns for the phosphorothioate oligonucleotide 5-
GCCCAAGCTGGCATCCGTCA-3 containing 2 substitutions of (a) deoxyribose, (b) ribose, and (c)
2O-methoxyethyl ribose corresponding to oligos 7, 8, and 9 respectively. The total amount of
fragmentation for each oligo has been normalized to 1. Each type of fragmentation includes
contributions from all charge states for the fragment.
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Fragmentation Patterns of Phosphorothioate
Oligonucleotides
Six phosphorothioate deoxyoligonucleotides ranging in
size from an 18- to a 21-mer were fragmented using
InHex IRMPD (Table 1, oligos 2–7). Sequence informa-
tion was obtained for 11–13 bases in from both the 5
and 3 ends with complementary fragments observed
for the 3–5 bases in the middle of the oligonucleotide,
resulting in complete sequence information for all six
oligonucleotides. A representative InHex IRMPD spec-
trum is shown in Figure 1A. The spectrum is dominated
by an-B and wn fragment ions that provide near com-
plete sequence coverage. Low level an, bn, cn, xn, and yn
fragment ions are observed as well. In addition to the
primary fragments, lower abundance species corre-
sponding to deadenylation, dehydration, and internal
fragmentation are observed.
Fragments that contain the 5 end of oligonucleotides
are dominated by the an-B fragment ions, which repre-
sent 30% of the total fragment ion abundance. With a
few minor exceptions, the fragment ion an-T is not
observed. In cases where the T occurs within 3 bases of
the 5 end or when there are multiple T’s in a row (i.e.,
TT) within 3 bases of the 5 end, the an-T fragment ion
is observed at low abundance. In addition to an-B
fragment ions, an, bn, and cn fragment ions are observed
at lower abundances (3.2%, 8.7%, 7.0%, respectively).
No dn fragment ions are observed for any of the
oligonucleotides studied under InHex IRMPD condi-
tions.
Fragments that contain the 3 end of the oligonucle-
otides are dominated by wn fragment ions, accounting
for 32.1% of the total fragment ion abundance. The
abundance of wn fragment ions formed by fragmenta-
tion 3 to a T are decreased relative to other bases. Also,
xn and yn fragment ions account for 3.3% and 15.7% of
the total fragment ion abundance, respectively. No zn
fragment ions were observed for any of the oligonucle-
otides studied under InHex IRMPD conditions.
For most phosphorothioate deoxyoligonucleotides in
the size range studied herein, identification of the an-B
and wn fragment ions yields complete sequence infor-
mation. The most abundant fragment ions correspond
to an-B or wn associated with the loss of an A and
fragmentation on the 3 side of the sugar from which
the A was lost. Oligonucleotides that have 5-TN-3
(where N  A, G, C, or T) as part of the sequence may
have gaps in the an-B and wn series because fragmen-
tation 3 to a T is disfavored. For example, if the a8-B
and a10-B fragment ions are observed but the a9-B
fragment ion is not observed, the mass difference be-
tween the a8-B and a10-B fragment ions will correspond
mostly likely to a T nucleotide and one other nucleotide.
Additionally, the T nucleotide will be at the 9th position
since no a9-B fragment ion was observed. A 5-NT-3
(where N  A, G, or C) as part of the sequence will not
cause a gap in the an-B and wn series since fragmenta-
tion will occur on the 3 side of N. In most cases, the
usually weak fragment ions an, bn, cn, xn, and yn can be
used to fill in the sequence gaps caused by 5-TN-3
sequences.
Table 2. Summed normalized abundances of the different fragment types for Oligo 1 (phosphodiester backbone, PO) and Oligo 2
(phosphorothioate ester backbone, PS)
Sequence
an an-B bn cn wn xn yn
PO PS PO PS PO PS PO PS PO PS PO PS PO PS
T
G
A 0.43 1.00
5 0.05 0.17 0.06 0.10
G 0.08 0.08 0.01 0.01
G 0.01 0.16 0.21
A 1.00 0.59 0.02
T 0.01 0.12 0.01 0.004
G 0.06 0.09
5 0.10 0.03 0.03 0.02
5 0.16 0.03 0.05
A 0.28 0.09 0.20 0.01
G 0.01 0.03 0.56 0.02 0.18 0.07
5 0.01 0.26 0.18
T 0.30 0.09 0.01 0.03
T 0.07
G 0.03
G 0.13 0.35 0.08
G 0.23 0.49 0.01 0.09
5 0.15 0.80
T
Note: 5  5-Methyl C.
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Fragment Patterns as a Function of 2 Sugar
Substituents
The same sequence was made as a phosphorothioate
oligonucleotide with three different substituents at the 2
position: (1) 2 deoxy (DNA), (2) 2 hydroxyl (RNA), and
(3) 2methoxyethyl (MOE) (Table 1, oligos 7, 8, and 9). The
fragmentation pattern changed as a function of the sub-
stituent at the 2 position (Figure 2 , Table 3). All three
oligonucleotides show significant fragmentation 10–13
bases from both the 3 and 5 ends. Under typical InHex
IRMPD conditions (500 ms irradiation times and 13.5
watts laser power), both the DNA and RNA sequence
fragment readily and generate abundant fragments rang-
ing 2 to 13 nucleotides in length (Figure 2A and B). In
contrast, the MOE sequence requires significantly higher
laser power (22 watts) and the resulting spectra are
dominated by relatively small cn and yn ions (2 to 5
nucleotides in length) (Figure 2C). Regardless, fragmenta-
tion ions yielding full sequence coverage were obtained
for all of these oligonucleotides.
The amount of an and an-B fragment ions decreased
as the 2 substituent was changed from a H to OH to
MOE (Table 3). The observed order of preference for
an-B fragment ions for DNA and RNA oligonucleotides
is ACGT. In contrast, the observed order of
preference for an-B fragment ions for a MOE oligo is
CGAT. The contribution from both bn and cn
fragment ions increases as the 2 sugar substituent is
changed (Table 3). Interestingly, the observed order of
preference for bn and cn fragment ions is not influenced
by the 2 substituent: CAGT and ACTG,
respectively.
The abundance of wn and yn fragment ions change
with the 2 substituent on the sugar but not in a
systematic fashion (Table 3). The observed order of
preference for formation of wn and yn fragment ions for
DNA and RNA sequences is: AGCT and
ACGT, respectively; while for MOE sequence, it
is: GTCA and CTGA, respectively. The con-
tribution from xn fragment ions increases as the 2 sugar
substituent is changed (see Table 3). The observed order
of preference for formation of xn fragment ions for DNA
and RNA sequences is CTGA. In contrast, the
observed preference for MOE sequence is TGCA.
For all three substituents, there is a decreased tendency
for fragmentation 3 to a T with the exception that an
intense w2 fragment ion is observed in the MOE se-
quence. In general, MOE sequences show significant
fragmentation 3 to a T within three bases of the 3
terminus of the oligonucleotide.
Fragmentation Patterns of Chimeric
Oligonucleotide
Chimeric oligonucleotides, in which the MOE moieties are
incorporated at the 2 position of the 4 most distal nucle-
otides of each end (MOE wings), are termed “gapmers”.
Gapmers are increasingly used as antisense compounds
since they have enhanced affinity and nuclease resistance
due to the MOE wings [31]. When there is a mixture of 2
substituents, fragmentation preferentially occurs at nucle-
otides with 2 deoxy groups instead of nucleotides that
contain 2methoxyethyl groups. As shown in Figure 3, the
fragmentation pattern of a phosphorothioate deoxyoligo-
nucleotide (Oligo 6) was compared to a phosphorothioate
gapmer oligonucleotide (Oligo 10) of the same sequence
which has MOE wings and deoxy groups in the gap
(Table 1). Overall, both Oligo 6 and 10 have similar
abundances of the different types of fragment ions: 1.1%
and 0.5 % an fragment ions; 20.6% and 23% an-B fragment
ions; 19.6% and 22.1% bn fragment ions; 3.9% and 3.9% cn
fragment ions; 20.8% and 18.7% wn fragment ions; 1.2%
and 1.7% xn fragment ions; and 32.8% and 30.1% yn
fragment ions, respectively (Figure 3). The fragmentation
patterns differ significantly only at the nucleotides that
have MOE groups in the 2 position. For example, Oligo 6
shows significant an-B and wn fragmentation throughout
the sequence while Oligo 10 shows significant an-B and wn
fragmentation only at the deoxynucleotides and not at the
MOE nucleotides. For Oligo 10, only significant amounts
of bn and yn fragment ions are observed at the MOE
wings. Identification of the bn, cn, xn, and yn fragment ions
is necessary to obtain complete sequence information for
Oligo 10.
General Fragmentation Patterns
From this study of fragmentation patterns of various
oligonucleotides, the following general observations
can be made:
1. For phosphorothioate and phosphodiester oligode-
oxynucleotides, the an-B and wn fragment ions domi-
nate with extensive fragmentation occurring 3 to A
nucleotides. Additionally, for 20 mer oligonucleotides,
complementary an-B and wn fragment ions are ob-
served when the fragments are close in length (e.g.,
a11-B and w9 are observed) but complementary frag-
ments are not observed when the two fragments are
differ significantly in length (e. g. a3 -B is observed but
w17 is not observed) 2. For oligonucleotides with hy-
droxyl or MOE groups, bn, cn, xn, and yn fragment ions
dominate with extensive fragmentation generally oc-
Table 3. Comparison of integrated fragment abundance (by type) as a function of 2 sugar substitute
Oligo an an-B bn cn wn xn yn
7 (2 deoxyribose) 8.0% 34.5% 2.4% 6.1% 33.2% 4.6% 11.2%
8 (ribose) 0.2% 5.2% 13.4% 16.2% 2.2% 21.4% 41.4%
9 (2 MOE) 0.8% 1.6% 11.6% 23.1% 12.3% 22.5% 28.2%
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curring 3 to A and C nucleotides. Similar to the
oligodeoxynucleotides, complementary bn and xn frag-
ment ions as well as complementary cn and yn ions are
observed near the middle of the sequence but for
20-mer oligonucleotides generally does not extend the
full length of the oligonucleotide. In most cases, the
complementary cn and yn fragment ions are more
intense than the complementary bn and xn fragment
ions. 3. For all oligonucleotides studied in this work,
decreased fragmentation is observed 3 to T nucleotides
regardless of the type of fragment ions formed. In most
cases, no an-B and wn fragment ions are observed at T
nucleotides regardless of the 2 substituent of the sugar.
Fragmentation Mechanisms Proposed
in the Literature
Several groups have proposed fragmentation mecha-
nisms to explain the observed an-B and wn fragment
ions. McLuckey and coworkers proposed a 2-step, 1,2
elimination scheme to explain the formation of an-B and
Figure 3. InHex IRMPD fragmentation patterns for the phosphorothioate oligonucleotide 5-
GATG55AGAGAGGATG55-3 in which the 2 substitutions are (a) uniformly deoxyribose (Oligo 6)
and (b) deoxyribose with MOE substituents on the 4 distal bases on each end (underlined bases)
(Oligo 10). The total amount of fragmentation for each oligonucleotide has been normalized to 1. Each
type of fragmentation includes contributions from all charge states for the fragment type.
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wn fragment ions where the base can be lost either as a
neutral or an anion [32]. They observed a preference for
base loss as AGTC. Rodgers et al. proposed a
proton bound intermediate to explain the loss of bases
as both neutrals and as anions [33]. They observed a
base loss preference of ATGC. Similar to the
McLuckey group, Barry and coworkers proposed a
base-catalyzed 2-step, 1,2 elimination scheme where the
negatively charged oxygen of the 3phosphodiester
group abstracts a proton from the 2 position of the
sugar resulting in base loss [13]. The observed prefer-
ence for nucleobase loss and subsequent formation of
an-B fragment ions is ATGC. Nordhoff et al.
proposed a charge remote, base elimination mechanism
whereby the base is protonated through an intramolec-
ular proton transfer followed by cleavage at the 5 and
3 phosphate [27]. The observed base loss preference
was AGCT. Gross and coworkers proposed an
intramolecular proton transfer from the 5phospate to
the base resulting in a zwitterionic intermediate from
which a neutral base is lost and subsequent cleavage
leads to formation of the an-B and wn ions [26, 28, 29].
Under ESI and source CAD conditions, Gross and
coworkers observed that the ease of formation of an-B
fragment ions is GCAT. The order of base loss
supports their proposed mechanism of protonation of
the base by the 5 phosphate group since the order
follows the proton affinity of the bases. It is interesting
to note that the preference for formation of an-B frag-
ment ions is dependent on the fragmentation scheme
employed.
All of the above mechanisms rely on the ability of the
3 phosphate group to interact with the 2 position of
the sugar. The fragmentation patterns of the 2 substi-
tuted oligonucleotides are consistent with the 3 phos-
phate group interacting with the 2 position of the
sugar. A significant decrease in an-B fragment ions is
observed when the 2 substituent is changed from
deoxy to hydroxyl to methoxyethyl group (Table 3). In
this study, changing from a deoxyoligonucleotide to
oligoribonucleotide, the amount of wn fragment ions
decreases. Interestingly, changing from an oligoribonu-
cleotide to a MOE oligonucleotide causes the formation
of wn fragment ions to increase. It is possible that an
alternative fragmentation pathway for formation of wn
fragment ions exists when the 2 substituent is a me-
thoxyethyl group that is not available when the 2
substituent is a hydroxyl group. Both the hydroxyl
group and the methoxyethoxyl group are electron with-
drawing, which stabilizes the N-gylcosidic bond and
makes protonation of the nucleobase unfavorable [34–
37]. This in turn makes loss of a base, which is required
for formation of the an-B fragment ion unfavorable.
Additionally, both the hydroxyl and the methoxyethyl
groups may sterically hinder the attack of the 3 phos-
phate group at the 2 position of the sugar.
Changing the 2 substituent of the sugar causes other
fragmentation pathways to become accessible and/or
dominant over the pathways that form an-B and wn
fragment ions. Recently, Leumann and coworkers have
proposed two pathways for formation of cn and yn
fragment ions in the fragmentation of oligoribonucleo-
tides [38]. One pathway involves the abstraction of the
2-hydroxyl proton by the 5-phosphate oxygen fol-
lowed by dissociation of the 5-P-1O bond. The second
pathway involves transfer of the acidic phosphate pro-
ton to the 5-oxygen followed by cleavage at the 5-P™O
bond. Both pathways for formation of cn and yn frag-
ment ions may be accessible for oligoribonucleotides
while only the second pathway is most likely accessible
for MOE oligonucleotides, consistent with the observa-
tion that yn fragment ions are more abundant in oligo-
ribonucleotides than in MOE oligonucleotides (Table 3).
Conclusions
When oligodeoxynucleotides are fragmented by InHex
IRMPD, it is primarily the an-B and wn fragment ions
that are most useful for sequence confirmation, regard-
less of whether the backbone is comprised of phos-
phodiester or phosphorothioate linkages. We have
shown that bn, cn, xn, and yn fragment ions provides
significant sequence information and are critical for
sequence confirmation of 2 modified oligonucleotides.
Although modifications at the 2 position of the sugar
render them more refractory to fragmentation, increas-
ing the laser power used for InHex IRMPD causes
fragmentation sufficient for sequence confirmation of
these oligonucleotides. In cases where there is a mixture
of 2’substituents, fragmentation predominately occurs
at the 2 deoxy groups. Regardless of the 2 substituent,
fragmentation 3 to a T is significantly decreased or
absent and may cause gaps in the sequence. However,
gaps in the sequence corresponding to a T nucleotide
plus an N nucleotide will have the sequence order
5-TN-3 and not 5-NT-3. Thus, gaps in the sequence
caused by lack of fragmentation do not prevent confir-
mation of the sequence. Based on the observations in
this study, the InHex IRMPD fragmentation scheme
provides a rapid and accurate means of sequence con-
firmation for modified oligonucleotides.
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